Harrison was a 4-year-old little boy who had a brilliant smile, loved Superman and enjoyed eating plain spaghetti noodles. Unfortunately Harrison passed away last year from hypoplastic left heart syndrome, or HLHS. Treatments are highly limited for this devastating disease and far too many children die from this condition world-wide.
Because of Harrison, we hosted a very special event at Mayo Clinic on HLHS. More than 200 physicians, researchers, lab personnel, children and parents from around the country gathered together to connect with one another, learn about HLHS research, share their personal stories, and work together to advance the care and treatment for those with this condition.
The work being done in the Center for Regenerative Medicine’s Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome is just one example of the innovative research being done at Mayo Clinic and pinpoints the pressing need to accelerate the translation of research discoveries into patient care. Patients and their families depend on these scientific discoveries every day.
Our Mayo Clinic staff hold their inspirations close to their hearts, and the inspiration Harrison has provided is no different — inspiring great work that will benefit the lives of many patients and families well into the future.
Editor's note: John Noseworthy, M.D., is the president and CEO of Mayo Clinic.
Tags: Center for Regenerative Medicine, Dr. John Noseworthy, Future of Health Care, health care, HLHS, hypoplastic left heart syndrome, John Noseworthy, Mayo Clinic, Noseworthy, Patient Care, research